The ORCA-3 study is being conducted to learn more about the effectiveness and safety of an oral medicine, cytisinicline, in combination with behavioral support in people trying to quit cigarette smoking.
Precision Clinical ResearchJune 12, 2022
© 2024 Precision Clinical Research.